Skip to main content

Table 2 Functional outcome of the 2 patient groups

From: Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment

Modified Harris Hip Score All Teriparatide-treated Non-Teriparatide- treated p-value
Postoperative 3 months 67.14 72 (70) 62.29 (65) 0.114
Postoperative 6 months 73.64 79 (78) 68.29 (73) 0.021*
Postoperative 1 year 81.57 84.29 (88) 78.86 (83) 0.384
Numerical Rating Scale
 Postoperative 7.38 7.25 (7) 7.5 (7.5) 0.582
 Postoperative 3 months 3.94 3.75 (3.5) 4.13 (4) 0.413
 Postoperative 6 months 3.25 2.63 (3) 3.88 (4) 0.042*
 Postoperative 9 months 1.94 1.38 (1.5) 2.5 (3) 0.139
 Postoperative 1 year 1.13 1 (1) 1.25(1) 0.628
 Recovery to pre-OP walking ability (%) 7 (53.8%) 5 (71.4%) 2 (33.3%) 0.217
  1. *p value < 0.05
  2. Data presented as mean (median)